Literature DB >> 31625155

Vaccines for emerging pathogens: from research to the clinic. Part two.

E D Williamson1.   

Abstract

For this two-part Clinical & Experimental Immunology Review Series, Guest Editor E. Diane Williamson invited experts in their fields to contribute articles on the status of vaccine research and development for emerging pathogens. Part One addressed our progress in developing vaccines for emerging and re-emerging viruses and considered current work on effective vaccines for bacterial pathogens. In this edition of the journal, we are pleased to present Part Two, in which our authors emphasise the importance of vaccine formulation and of the use of effective delivery vehicles, as well as the prospects for licensure for current candidate vaccines.
© 2019 British Society for Immunology.

Keywords:  host-pathogen interactions; vaccination; viral

Year:  2019        PMID: 31625155      PMCID: PMC6797869          DOI: 10.1111/cei.13378

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  8 in total

Review 1.  Novel multi-component vaccine approaches for Burkholderia pseudomallei.

Authors:  L Morici; A G Torres; R W Titball
Journal:  Clin Exp Immunol       Date:  2019-04-08       Impact factor: 4.330

Review 2.  Mucosal vaccines and technology.

Authors:  A Miquel-Clopés; E G Bentley; J P Stewart; S R Carding
Journal:  Clin Exp Immunol       Date:  2019-04-08       Impact factor: 4.330

Review 3.  Emerging viruses and current strategies for vaccine intervention.

Authors:  B Afrough; S Dowall; R Hewson
Journal:  Clin Exp Immunol       Date:  2019-05       Impact factor: 4.330

Review 4.  HLA-E: exploiting pathogen-host interactions for vaccine development.

Authors:  H R Sharpe; G Bowyer; S Brackenridge; T Lambe
Journal:  Clin Exp Immunol       Date:  2019-04-09       Impact factor: 4.330

Review 5.  Novel approaches for the design, delivery and administration of vaccine technologies.

Authors:  J Wallis; D P Shenton; R C Carlisle
Journal:  Clin Exp Immunol       Date:  2019-04-08       Impact factor: 4.330

Review 6.  Vaccines for emerging pathogens: prospects for licensure.

Authors:  E D Williamson; G E Westlake
Journal:  Clin Exp Immunol       Date:  2019-04-11       Impact factor: 4.330

Review 7.  A novel vaccine platform using glucan particles for induction of protective responses against Francisella tularensis and other pathogens.

Authors:  A Abraham; G Ostroff; S M Levitz; P C F Oyston
Journal:  Clin Exp Immunol       Date:  2019-09-12       Impact factor: 4.330

Review 8.  Formulation technologies for oral vaccines.

Authors:  R R C New
Journal:  Clin Exp Immunol       Date:  2019-08-08       Impact factor: 4.330

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.